Dogwood Therapeutics has a market capitalization of $66.14 million and a price-to-book ratio of 0.88, indicating that the company is trading at a discount relative to its book value. The company ha…
EAH.L maintains a strong liquidity position, with GBP 25.006 million in cash and equivalents, and a current ratio of 3.21, indicating the company can easily cover its short-term liabilities. The co…
Ekso Bionics operates with a market capitalization of $42.8 million and a price-to-book ratio of 3.55, indicating a premium valuation relative to its equity base. The company's liquidity position i…
Estrella Immunopharma Inc has a negative equity position of -$10,366,060 and a current ratio of 0.12, indicating significant liquidity constraints. The company's cash and equivalents amount to $1,3…
Filana Therapeutics Inc has a strong liquidity position, with a current ratio of 4.07 and cash and equivalents amounting to $207.29 million, indicating a robust ability to meet short-term obligatio…
Gentian Diagnostics maintains a strong liquidity position, with a current ratio of 5.4 and cash and equivalents of NOK 105.9 million, which is significantly higher than the industry median. The com…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.02, indicating a conservative leverage position. However, the company is experiencing negative free cash flow of…
HEALTH.HE has a market price of 0.86 EUR and a market cap of 34,860,253.94 EUR, indicating a relatively small capitalization. The company's price-to-book ratio is 0.53, and its price-to-tangible-bo…
Hyperfine operates with a strong liquidity position, holding $35.09 million in cash and equivalents, which represents 63.5% of total assets. The company has no long-term debt and a debt-to-equity r…
Medios AG has a debt-to-equity ratio of 0.39 and a current ratio of 1.9, indicating a relatively balanced capital structure with moderate liquidity. However, the company's cash and equivalents are…
IMVT.O has a market capitalization of $5.84 billion and a price-to-book ratio of 8.25, indicating a premium valuation relative to its book value. The company has no long-term debt and a debt-to-equ…
InfuSystem operates with a debt-to-equity ratio of 0.34 and a current ratio of 1.8, indicating moderate leverage and adequate short-term liquidity. The company's price-to-book ratio of 3.09 and pri…
Jushi Holdings Inc has a negative equity position of -$22.2 million and a debt-to-equity ratio of -12.09, indicating a highly leveraged capital structure with negative net worth. The company mainta…
LifeVantage maintains a strong liquidity position with $20.2 million in cash and equivalents, representing 55.4% of total assets. The company's liquidity FPT (free cash flow to total liabilities) i…
LNA.PA has a market price of 31.9 EUR, with a market capitalization of 327,192,207.1 EUR. The company's price-to-earnings ratio is 13.55, and its price-to-book ratio is 0.99, indicating a relativel…
M1 Kliniken AG has a market capitalization of EUR 356.79 million, with a current market price of EUR 19.00 per share. The company has 18.78 million shares outstanding, with no dilution from diluted…
Marksans Pharma Ltd maintains a strong liquidity position, with a current ratio of 4.62, indicating the company can easily cover its short-term liabilities with its short-term assets. The company's…
Microbot Medical Inc has a market capitalization of $124.24 million and a price-to-book ratio of 20.52, indicating a premium valuation relative to its book value. The company holds $2.47 million in…
Medicover AB maintains a capital structure with a debt-to-equity ratio of 2.64, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with a c…
Medincell's capital structure is highly leveraged, with total liabilities of EUR 106.8 million and total equity of EUR -16.4 million, resulting in a negative net worth. The company's liquidity posi…
Nordhealth AS has a strong liquidity position with a current ratio of 2.21, indicating the company can cover its short-term liabilities with its current assets. The company holds EUR 14.7 million i…
Nykode Therapeutics has a strong liquidity position, with a current ratio of 10.0 and cash and equivalents amounting to $59.86 million, which significantly exceeds its total liabilities of $8.42 mi…
OPTI.KL maintains a debt-to-equity ratio of 0.67, indicating a moderate level of leverage, and a current ratio of 1.52, suggesting reasonable short-term liquidity. The company's return on equity (R…
Ortoma AB operates with a capital structure that is entirely equity-funded, as evidenced by a debt-to-equity ratio of 0.0. The company's liquidity position is characterized by a current ratio of 3.…
Piq A maintains a strong liquidity position, with a current ratio of 9.39, indicating a high ability to meet short-term obligations. The company holds significant cash and equivalents of AUD 9,416,…
Quince Therapeutics Inc has a market capitalization of $19.23 million and a price-to-book ratio of 0.41, indicating that the company is trading at a significant discount to its book value. The comp…
Royalty Pharma maintains a capital structure with a debt-to-equity ratio of 0.94, indicating a moderate reliance on debt financing. The company holds $843 million in cash and equivalents, but its l…
The company's capital structure is characterized by a market cap of 46,629,156,883.4 GBP and a price-to-book ratio of 939.33, indicating a high valuation relative to its book value. The liquidity p…
Stevanato Group maintains a levered capital structure with a debt-to-equity ratio of 0.32 and a current ratio of 1.76, indicating moderate liquidity risk. The company's price-to-book ratio of 3.64…
Tactile Systems Technology Inc maintains a strong liquidity position, with a current ratio of 4.03 and $83.45 million in cash and equivalents, representing 30.5% of total assets. The company has no…
TNH.HM's capital structure is characterized by a debt-to-equity ratio of 0.61, indicating a moderate level of leverage. The company's liquidity is assessed as medium, with a current ratio of 0.9, s…
Tristel maintains a strong liquidity position with GBP 8.644 million in cash and equivalents, and a current ratio of 3.6, indicating a robust ability to cover short-term liabilities. The company's…
Unicycive Therapeutics Inc has a market capitalization of $219.74 million and a price-to-book ratio of 7.28, indicating that the market is valuing the company at a premium to its book value. The co…
Auxly Cannabis Group Inc has a liquidity position that is below the industry median, with a current ratio of 0.71, indicating that the company's current assets are insufficient to cover its current…
C.Q. Pharmaceutical Holding Co Ltd has a market capitalization of CNY 10.42 billion and a price-to-earnings ratio of 26.95, which is relatively high compared to the industry median. The company's p…
The company maintains a strong capital structure, with a current ratio of 2.36, indicating a solid ability to meet short-term obligations. Free cash flow of 1.16 billion CNY and operating cash flow…
Haisco Pharmaceutical Group Co Ltd maintains a debt-to-equity ratio of 0.52, indicating a relatively conservative capital structure with a moderate reliance on debt financing. The company's liquidi…
The company's capital structure shows a debt-to-equity ratio of 0.65, indicating a moderate level of leverage. However, the liquidity position is constrained, with a current ratio of 0.82, suggesti…
I Sens Inc's capital structure is characterized by a debt-to-equity ratio of 0.55, indicating a moderate level of leverage. The company's liquidity position is marked by a current ratio of 1.55, su…
St.Shine Optical maintains a strong liquidity position, with a current ratio of 3.87 and cash and equivalents of TWD 1.18 billion, representing 15.14% of total assets. The company's debt-to-equity…
The company's capital structure shows a debt-to-equity ratio of 0.26, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, and its free ca…
The company maintains a strong liquidity position, with a current ratio of 5.2, indicating a robust ability to meet short-term obligations. Free cash flow for the period was CNY 236.6 million, whil…
Everest Medicines operates with a capital structure that includes a debt-to-equity ratio of 0.17, indicating a relatively low leverage position. The company's liquidity position is characterized by…
WuXi XDC Cayman Inc has a market capitalization of 72.5 billion CNY, with a current market price of 57.5 CNY per share. The company's shares outstanding are 1.26 billion, with no dilution observed…
The company maintains a strong liquidity position, with cash and equivalents amounting to CNY 1.52 billion, significantly exceeding its total liabilities of CNY 1.58 billion, resulting in a current…
Findex Inc maintains a strong liquidity position, with cash and equivalents amounting to ¥2.896 billion, representing 44.2% of total assets. The company operates with no long-term debt, resulting i…
The company maintains a strong liquidity position, with a current ratio of 3.13, indicating that it has more than three times the current assets to cover its current liabilities. However, the liqui…
Nxera Pharma maintains a debt-to-equity ratio of 0.94 and a current ratio of 2.54, indicating moderate leverage and strong short-term liquidity. The company's price-to-book ratio of 1.59 suggests a…
The company's capital structure is characterized by a high debt-to-equity ratio of 1.5, indicating a significant reliance on debt financing. Despite holding JPY 5.68 billion in cash and equivalents…
CellSource maintains a strong liquidity position, with cash and equivalents amounting to ¥4.599 billion, representing 66.8% of total assets. The company's liquidity FPT (free cash flow to total lia…
LivsMed Inc has a highly liquid capital structure, with cash and equivalents of KRW 11.4 billion and a current ratio of 12.68, indicating strong short-term liquidity. However, the company has a neg…
The company maintains a strong liquidity position, as evidenced by a current ratio of 10.2, indicating that it has significantly more current assets than current liabilities. However, its operating…
The company maintains a strong liquidity position, with cash and equivalents amounting to TWD 500 million, representing 4.3% of total assets. The price-to-book ratio of 4.57 and a current ratio of…
ABIS.MI maintains a strong liquidity position, with a current ratio of 7.74 and cash and equivalents of 1,342,610 EUR, indicating a robust ability to meet short-term obligations. The company's debt…
Adicet Bio Inc maintains a strong liquidity position, with a current ratio of 7.47 and cash and equivalents of $38.9 million, which is significantly higher than the industry median. The company's p…
Diagnostic Medical Systems SA has a fully diluted share count of 26.69 million shares, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock option…
Allarity Therapeutics Inc maintains a strong liquidity position, with cash and equivalents amounting to $14.69 million, which significantly exceeds its total liabilities of $8.43 million, resulting…
Aurobindo Pharma Ltd has a revenue of INR 79,785.2 million, with a gross profit of INR 46,631.1 million and an operating income of INR 12,092.8 million. The company's net income is INR 8,458.1 mill…
The company's capital structure is characterized by a debt-to-equity ratio of 0.25, indicating a relatively conservative leverage position compared to the industry median. However, the liquidity po…
The company's capital structure is characterized by a current ratio of 4.0, indicating strong short-term liquidity. However, the operating cash flow of -78.58 million AUD and free cash flow of -85.…
Barinthus maintains a strong liquidity position, with $117.8 million in cash and equivalents and a current ratio of 8.46, indicating a robust ability to meet short-term obligations. The company has…
Cairo Communication has a liquidity position that is currently rated as medium, with EUR 57.9 million in cash and equivalents and EUR 201.5 million in long-term debt, resulting in a net cash positi…
Cibus Inc has a market capitalization of $114.42 million and a price-to-book ratio of 5.24, indicating that the market is valuing the company at a premium to its book value. The company's liquidity…
Cingulate Inc operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of 2.97, indicating significant reliance on debt financing. The company maintains a liquidit…
Cardiol Therapeutics Inc maintains a strong liquidity position, with cash and equivalents amounting to CAD 21.42 million, which significantly exceeds its total liabilities of CAD 5.74 million, resu…
Journey Medical Corp has a market capitalization of $135.55 million and a price-to-book ratio of 4.26, indicating a premium valuation relative to its book value. The company holds $24.09 million in…
Central Pharmaceutical JSC No3 maintains a strong liquidity position, as evidenced by a current ratio of 2.77, indicating that the company has more than double the current assets to cover its curre…
DarioHealth operates with a capital structure that shows a debt-to-equity ratio of 0.45, indicating a relatively conservative leverage position. The company holds $26.0 million in cash and equivale…
Edison Pharmaceuticals operates with a negative equity position of CAD -69.72 million and a debt-to-equity ratio of -0.3, indicating a capital structure heavily reliant on debt financing. The compa…
Gilead Sciences Inc has a market capitalization of $163.01 billion and a price-to-book ratio of 9.29, indicating a premium valuation relative to its book value. The company's liquidity position is…
HAEK.H maintains a strong liquidity position, with a current ratio of 2.59, indicating the company can cover its short-term liabilities more than two times over. The company holds EUR 23.81 million…
Inspira Technologies Oxy BHN Ltd maintains a strong liquidity position, with $3.16 million in cash and equivalents, representing 59.1% of total assets. The company has no long-term debt and a curre…
Indoco Remedies Ltd has a debt-to-equity ratio of 0.97, indicating a moderate level of leverage, and a current ratio of 1.24, suggesting limited short-term liquidity cushion. The company reported n…
Kamada maintains a strong liquidity position, with a current ratio of 4.07 and cash and equivalents of $37.25 million, indicating a solid ability to meet short-term obligations. The company's liqui…
Limes Schlosskliniken AG maintains a strong liquidity position with a current ratio of 2.92, indicating the company can cover its short-term obligations more than two and a half times over. However…
MAAT.PA's capital structure is highly leveraged, with a debt-to-equity ratio of 9.69, indicating significant reliance on debt financing. The company's liquidity position is moderate, with a current…
MEDA.NS maintains a relatively strong liquidity position, with a current ratio of 1.49, indicating the company can cover its short-term liabilities with its short-term assets. However, the company'…
Medistim maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating limited leverage and a strong equity base. The company's liquidity position is reflected in a cur…
Mirum Pharmaceuticals has a liquidity position characterized by $296.68 million in cash and equivalents, which is offset by $309.80 million in long-term debt, resulting in a net cash position of -$…
Merck's capital structure shows a debt-to-equity ratio of 0.85, indicating a moderate reliance on debt financing. The company holds $5.58 billion in cash and equivalents but faces a net cash defici…
Nyxoah's capital structure is characterized by a low debt-to-equity ratio of 0.15, indicating a conservative leverage profile. The company maintains a strong liquidity position with a current ratio…
OmniAb operates with a strong liquidity position, as evidenced by a current ratio of 4.02 and $25.52 million in cash and equivalents, despite a negative operating cash flow of -$36.46 million. The…
Orchestra Biomed's capital structure is characterized by a low debt-to-equity ratio of 0.23, indicating a conservative leverage profile. The company holds $34.69 million in cash and equivalents, wh…
ORCD.NS maintains a conservative capital structure with a debt-to-equity ratio of 0.14, indicating a low reliance on debt financing. The company's liquidity position is strong, as evidenced by a cu…
Pro Medicus operates with a fully diluted share count of 104,469,963 shares, matching its basic share count, indicating no dilution from stock options or convertible securities. The company's marke…
The company maintains a strong liquidity position, with a current ratio of 2.44 and cash and equivalents of INR 898.1 million, indicating a solid ability to meet short-term obligations. The low deb…
Poltreg SA maintains a strong liquidity position, with cash and equivalents amounting to 45.76 million PLN, representing 38.7% of total assets. The company's liquidity FPT (free cash flow to total…
QuidelOrtho operates with a debt-to-equity ratio of 1.38 and a current ratio of 1.5, indicating moderate liquidity risk. The company holds $169.8 million in cash and equivalents but faces a negativ…
RaySearch Laboratories maintains a debt-to-equity ratio of 0.65 and a current ratio of 1.2, indicating moderate leverage and liquidity. The company holds SEK 435.2 million in cash and equivalents,…
Soligenix Inc has a liquidity position characterized by a current ratio of 1.52 and a cash and equivalents balance of $9.41 million, which is significantly higher than its total liabilities of $6.4…
Synektik maintains a strong liquidity position with a current ratio of 1.65 and cash and equivalents of 84.25 million PLN, which supports operational flexibility and short-term obligations. The com…
TGTX's capital structure is characterized by a market cap of $5.53 billion and a price-to-book ratio of 8.53, indicating a premium valuation relative to its book value. The company's liquidity posi…
The company maintains a conservative capital structure, with a debt-to-equity ratio of 0.3, indicating limited leverage. Free cash flow of 2.996 billion CNY supports operational flexibility, though…
The company maintains a strong liquidity position, with a current ratio of 6.48 and cash and equivalents amounting to 52,371,957,700 KRW, indicating a robust ability to meet short-term obligations.…
Sisram Medical maintains a conservative capital structure with a debt-to-equity ratio of 0.11, indicating minimal leverage and a strong equity base. The company holds $70.8 million in cash and equi…
The company maintains a strong liquidity position, with a current ratio of 8.7, indicating a high ability to meet short-term obligations. It also has a free cash flow of 43,712,898,420 KRW, which s…
MicroTech Medical (Hangzhou) Co Ltd has a basic and diluted share count of 416,064,000 shares, indicating no immediate dilution pressure from share issuance. However, liquidity risk could not be as…
The company maintains a strong liquidity position, with a current ratio of 2.96, indicating a robust ability to meet short-term obligations. Its price-to-book ratio of 1.68 and price-to-tangible-bo…
The company has a market capitalization of 23.19 billion CNY, with a current market price of 45.98 CNY per share. The capital structure is undiluted, as the number of basic and diluted shares outst…
Tianjin Chase Sun Pharmaceutical Co Ltd maintains a conservative capital structure, with a debt-to-equity ratio of 0.07, indicating minimal leverage. The company's liquidity position is characteriz…
The company maintains a strong liquidity position, with a current ratio of 2.71, indicating sufficient short-term assets to cover liabilities. However, its free cash flow is negative at -20.43 mill…
The company maintains a strong liquidity position, with a current ratio of 6.23 and cash and equivalents amounting to 8,142,114,540 KRW. The price-to-book ratio is 13.5, indicating a premium valuat…
The company's capital structure is characterized by a debt-to-equity ratio of 0.48, indicating a relatively conservative leverage position. However, the company's liquidity is assessed as medium, w…
Fuji Pharma maintains a conservative capital structure with a debt-to-equity ratio of 0.66, indicating a balanced approach to financing. The company's liquidity position is characterized as medium,…
The company maintains a strong liquidity position, with cash and equivalents amounting to ¥2,995,435,000, which significantly exceeds its total liabilities of ¥5,597,519,000, as reflected in the cu…
Mizuho Medy maintains a strong liquidity position, with cash and equivalents amounting to ¥10.825 billion, representing nearly 48% of its total assets. The company's liquidity FPT (free cash flow t…
The company's capital structure is characterized by a high price-to-book ratio of 285.68, indicating a significant premium over its book value. Its liquidity position is marked by a current ratio o…
Toshiba's capital structure shows a debt-to-equity ratio of 0.13, indicating a relatively low level of leverage compared to industry norms. The company's liquidity position is characterized by a cu…
The company's capital structure is characterized by a debt-to-equity ratio of 0.2, indicating a relatively low reliance on debt financing. However, its liquidity position is assessed as low, with a…
(a) Capital structure and liquidity details are not available in the current dataset, as balance-sheet inputs are absent. Consequently, liquidity risk cannot be assessed, and no going-concern langu…
aTyr Pharma maintains a strong liquidity position with a current ratio of 5.3, supported by $10.74 million in cash and equivalents and total assets of $93.00 million. The company's debt-to-equity r…
The company's capital structure is characterized by a debt-to-equity ratio of 0.71, indicating a moderate reliance on debt financing. Its liquidity position is marked by a current ratio of 1.78, su…
ContextVision maintains a strong liquidity position with cash and equivalents of 64.9 million SEK, representing 55% of total assets, and a current ratio of 3.38, well above the industry median. The…
Icecure Medical operates with a strong liquidity position, as evidenced by $10.97 million in cash and equivalents, which represents 68.3% of total assets. The company has no long-term debt, and its…
Imugene operates with a fully diluted share count of 415.8 million shares, with no difference between basic and diluted shares outstanding, indicating no immediate dilution risk from stock options…
IPD.AX has a liquidity position that is relatively strong, with a current ratio of 4.86, indicating that the company has more than four times as many current assets as current liabilities. However,…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.01, indicating a conservative leverage position. It maintains a strong liquidity position with a current ratio of…
Lupin Limited has a debt-to-equity ratio of 0.48, indicating a relatively conservative capital structure. The company's liquidity is assessed as medium, with a current ratio of 1.33, suggesting it…
LeMaitre Vascular Inc maintains a strong liquidity position with a current ratio of 12.89, indicating a robust ability to meet short-term obligations. The company's liquidity_fpt score is high, sup…
Spectral AI operates with a cash balance of $15.4 million against $27.1 million in total liabilities, resulting in a negative equity position of $5.7 million. The company's liquidity position is ra…
Malin Corporation PLC has a fully diluted share count of 4,326,168, with no difference between basic and diluted shares outstanding, indicating no dilution risk from stock options or convertible se…
NeuroOne's capital structure is characterized by a market cap of $38.74 million and a price-to-book ratio of 10.05, indicating a premium valuation relative to its book value. The company has no lon…
Neurosense Therapeutics operates with a negative equity position of $6.99 million and a total asset base of $1.45 million, indicating a highly leveraged and capital-intensive structure. The company…
NRX Pharmaceuticals Inc operates with a negative equity position of -$15.94 million and a total asset base of $12.96 million, indicating a highly leveraged and capital-intensive structure. The comp…
NeOnc Technologies has a market capitalization of $138.06 million with a share price of $5.46, but its capital structure is constrained by a negative net income of -$2.94 million and operating loss…
The company's capital structure is highly leveraged, with a debt-to-equity ratio of 4.58, indicating significant reliance on debt financing. Despite holding GBP 1.392 billion in cash and equivalent…
Oncopeptides operates with a negative equity position of -58.89 million SEK and a total debt of 139.39 million SEK, resulting in a debt-to-equity ratio of -2.37, indicating a highly leveraged capit…
Palisade Bio Inc has a highly liquid capital structure, with cash and equivalents amounting to $133.39 million, significantly exceeding its total liabilities of $4.96 million, resulting in a curren…
RJH.BK maintains a debt-to-equity ratio of 0.65, indicating a moderate level of leverage, and a current ratio of 0.71, suggesting potential liquidity constraints as current liabilities exceed curre…
Sareum Holdings PLC has a basic and diluted share count of 138,065,173, indicating no immediate dilution pressure from share-based compensation or convertible instruments. However, the company's li…
The company's capital structure is characterized by a high price-to-book ratio of 268.27, indicating a significant premium over its book value. Despite holding substantial cash and equivalents of 4…
Senores Pharmaceuticals Ltd maintains a debt-to-equity ratio of 0.4, indicating a relatively conservative capital structure with a strong equity base. The company's liquidity position is characteri…
Senseonics operates with a liquidity position that is medium-risk, as indicated by its negative net cash position after subtracting total debt. The company's liquidity FPT (free cash flow to total…
Sight operates with a highly leveraged capital structure, as evidenced by a negative total equity of EUR -24.94 million and a debt-to-equity ratio of -0.52, indicating that liabilities exceed equit…
SINTX Technologies Inc exhibits a capital structure with a debt-to-equity ratio of 0.02, indicating minimal leverage and a strong equity position. The company holds $5.76 million in cash and equiva…
SLD.AX's capital structure is highly leveraged, with total liabilities of $234.2 million and total equity of -$105.5 million, resulting in a debt-to-equity ratio of -1.94. The company's liquidity p…
SANUWAVE Health Inc operates with a highly leveraged capital structure, as evidenced by a debt-to-equity ratio of 13.56, indicating significant reliance on debt financing. The company's liquidity p…
Venus Remedies Ltd maintains a strong liquidity position, with a current ratio of 4.53, indicating that the company has more than four times the current assets to cover its current liabilities. The…
The company's capital structure is characterized by a low debt-to-equity ratio of 0.09, indicating a conservative approach to leverage. With $44.7 million in cash and equivalents and $24.1 million…
Wanbangde Pharmaceutical Holding Group Co Ltd has a debt-to-equity ratio of 0.44, indicating a relatively conservative capital structure. However, the company reported negative net income of -167.2…
Pharmicell maintains a strong liquidity position with a current ratio of 9.82, indicating a significant buffer of current assets over current liabilities. The company holds KRW 5,025,559,800 in cas…
The company maintains a strong liquidity position, with a current ratio of 3.1, indicating a solid ability to meet short-term obligations. However, its price-to-book ratio of 0.62 suggests that the…
Binex Co Ltd's capital structure shows a debt-to-equity ratio of 0.52, indicating moderate leverage relative to its equity base. However, the company's liquidity position is concerning, with negati…
Sinopharm Group Co Ltd has a debt-to-equity ratio of 0.85, indicating a moderate level of leverage, and a current ratio of 1.41, suggesting it has sufficient short-term assets to cover its short-te…
Structure and Liquidity EuBiologics maintains a strong liquidity position with $1.45 billion in cash and equivalents, representing 9.4% of total assets. The company's current ratio of 1.81 indicate…
GNI Group Ltd has a strong liquidity position, with cash and equivalents amounting to ¥16.3 billion, which is significantly higher than its long-term debt of ¥6.02 billion, resulting in a debt-to-e…
XtalPi's capital structure is characterized by a lack of disclosed balance-sheet inputs, which prevents a full liquidity assessment. The company has no dilution risk in the near term, as shares out…
Biocytogen Pharmaceuticals has a market capitalization of 5.45 billion CNY, with a market price of 49.22 CNY per share. The company has 110,781,920 basic and diluted shares outstanding, indicating…
The company has a market capitalization of 2,599,811,036.48 CNY, with a market price of 22.82 CNY per share. The shares outstanding are 113,926,864 for both basic and diluted shares, indicating no…
Vi sender deg én e-post når Handelsavisen lanseres. Ingen spam, ingen annen bruk.
Ved å registrere deg samtykker du til å motta ett enkelt varsel fra Handelsavisen på lanseringsdagen.